This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vivus (VVUS)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -82.65M -174.95M -139.73M -47.03M
Operating Gains/Losses 0.00 0.00 -8.00K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 619.00K -9.44M -2.83M 0.00
(Increase) Decrease in Inventories 11.89M -30.20M -22.05M 118.00K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -329.00K -14.82M 22.20M 545.00K
(Decrease) Increase In Other Current Liabilities -9.06M 13.17M 7.38M 15.00K
(Increase) Decrease In Other Working Capital 706.00K 26.46M 1.15M 0.00
Other Non-Cash Items 11.94M 40.58M 15.99M 7.35M
Net Cash From Continuing Operations -38.10M -135.12M -131.32M -39.04M
Net Cash From Discontinued Operations 0.00 -208.00K -885.00K -980.00K
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -38.10M -135.32M -132.20M -40.02M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 260.50M 242.50M 174.01M 132.12M
Purchases of Property, Plant & Equipment -262.00K -1.79M -1.67M -201.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -240.98M -329.14M -226.65M 0.00
Other Cash from Investing Activities -3.36M -1.68M 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 15.89M -90.12M -54.31M -5.49M
Issuance of Debt 0.00 290.25M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.12M 14.56M 205.56M 47.85M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -34.71M 0.00 0.00
Net Cash From Financing Activities 2.12M 270.10M 205.56M 47.85M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -20.09M 44.66M 19.05M 2.34M
VVUS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for VVUS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 1 1 1
Hold 2 2 2 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET VVUS ANALYST REPORT

VVUS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs